FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs

Agency Recommendations Aim to Inform Psychedelic Drug Development SILVER SPRING, Md., June 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs…